The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A global phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma.
 
Nader Sanai
No Relationships to Disclose
 
Shwetal Mehta
No Relationships to Disclose
 
An-Chi Tien
No Relationships to Disclose
 
Artak Tovmasyan
No Relationships to Disclose
 
Jocelyn Harmon
No Relationships to Disclose
 
William Kennedy
No Relationships to Disclose
 
Amine Aziez
Employment - GlaxoSmithKline
 
Anthony Chalmers
No Relationships to Disclose
 
Mustafa Khasraw
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; George Clincal; Janssen; Lilly; Novocure; Roche; SERVIER; Stemline Therapeutics; Voyager Therapeutics
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); cns pharmaceuticals (Inst); daiichi Sankyo (Inst); Immorna (Inst); Immvira (Inst); Personalis (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Mary Jane Lim-Fat
Honoraria - Novocure; SERVIER
Consulting or Advisory Role - Canadian Agency for Drugs and Technologies in Health (CADTH); Cancer Care Ontario
 
Giuseppe Minniti
No Relationships to Disclose
 
Juan Sepúlveda
No Relationships to Disclose
 
Mehdi Touat
Consulting or Advisory Role - Agios; Integragen; NH TherAguix; Novocure; SERVIER; Taiho Pharmaceutical
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; SERVIER
 
Yoshie Umemura
Consulting or Advisory Role - Aptitude Health; OncLive/MJH Life Sciences; SERVIER
Speakers' Bureau - SERVIER
Research Funding - BTG (Inst); Chimerix (Inst); Ono Pharmaceutical (Inst); SERVIER (Inst)